Latest filing published 06 Sept 2006 for INTROGEN THERAPEUTICS INC, €62k.
No signal scores available.
Aventis Inc. is a declared insider of Introgen Therapeutics Inc, with filings sourced from SEC (Form 4). In total, 21 filings cover trades dated from 16 March 2006 to 6 September 2006.
Sales make up the whole of the open-market record (21 sales, €2.2M).
The newest entry dates from 6 September 2006: an open-market sale of €62k, in Introgen Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations